TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07338838: A Phase I Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of TQB3142 for Injection in Patients With Advanced Malignant Tumors

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 66 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$1,979,208

Rescue Site Savings

+$1,319,472

Unlock Full NCT07338838 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07338838 Rescue Dossier →